Skip to content

Clinical trials

Observational Pulmonary Embolism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Observational Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20053
20066
20071
20083
20091
20102
20113
20124
20132
20142
20154
20165
20173
20185
20193
20205
20214
20222
20231
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting6
Withdrawn4
Terminated3
Unknown status3
Active, not recruiting2
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital13
Wake Forest University Health Sciences3
Diagnostica Stago2
Inari Medical2
Mayo Clinic2
The Cleveland Clinic2
University of Texas Southwestern Medical Center2
Abbott RDx Cardiometabolic1
Atlantic Health System1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism67
Venous Thrombosis29
Venous Thromboembolism16
Thrombosis8
Thromboembolism7
Neoplasms6
Heart Failure5
Atrial Fibrillation4
Acute Coronary Syndrome3
Coronary Artery Disease3

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.